YOLFTbeta
II

Inoviq Ltd

IIQ · AU · Healthcare / Diagnostics & Research

0.125AUD-0.01 (-3.85%)

Price History

Full chart

Market Stats

Previous Close0.13
Open0.13
Day Range0.125 – 0.13
52-Week Range0.16 – 0.565
Volume93.24K
Market Cap23.93M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
Beta1.54
50-Day Avg0.1818
200-Day Avg0.2999

About

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an immunoaffinity magnetic bead-based isolation system for exosome isolation from plasma, serum, urine, saliva and cell-conditioned medium. It also offers non-invasive diagnostics using its proprietary exosome development technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. Leearne Maree Hinch B.Sc., B.V.M.S., M.B.A., M.R.C.V.S.
  • Employees0
  • Headquarters23 Normanby Road, Notting Hill, VIC, Australia, 3168, Australia
  • Websitehttps://www.inoviq.com

Leadership

  • Dr. Leearne Maree Hinch B.Sc., B.V.M.S., M.B.A., M.R.C.V.S.Chief Executive Officer
  • Mr. Mark Edwards BACC, C.A.CFO & Company Secretary
  • Dr. Rebecca Lim B.Sc., Ph.D.Chief Scientific Officer
  • Dr. Emma Ball B.Sc., M.B.A., Ph.D.Chief Commercial Officer

Financials

Income Statement

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-----------1.24M621.47K356.34K296.90K77.69K-5.72M11.78K182.89K5.16K275.68K----44.03K62.42K8.73K98.39K1.27M276.75K398.19K535.12K1.82M432.05K
Growth (%)-------------50.08%-42.66%-16.68%-73.83%---99.79%+1452.28%-97.18%+5243.63%-----+41.77%-86.01%+1027.03%+1191.80%-78.23%+43.88%+34.39%+239.24%-76.20%
Cost of Revenue-----------337.38K167.78K101.01K40.44K94.52K---------4.25K8.01K951.70K713.76K684.90K3.48M2.16M1.44M81.01K3.37M1.41M
Gross Profit-----------907.49K453.69K255.33K256.46K-16.84K-5.72M11.78K182.89K5.16K275.68K----4.25K-8.01K-889.00K-192.96K-149.80K-2.21M-1.88M-1.04M454.11K-1.56M-974.92K
Gross Margin-----------72.90%73.00%71.65%86.38%-21.67%-100.00%100.00%100.00%100.00%100.00%-----18.19%-1424.27%-2210.34%-152.25%-173.80%-679.79%-261.18%84.86%-85.91%-225.65%
Operating Expense-----------1.05M1.90M1.49M2.61M3.61M-1.01M1.15M1.16M1.24M1.28M---242.75K2.49M1.25M2.11M2.75M7.89M7.12M9.38M8.25M9.04M8.69M
Operating Income-4.87M-494.00K-428.00K-584.00K25.00K-445.00K169.00K13.61K153.99K-657.00K-1.59M-141.69K-1.45M-1.23M-2.35M-3.62M-370.00K4.71M-1.14M-977.00K-1.23M-1.01M-122.00K-180.00K-37.87K-247.00K-2.50M-2.14M-2.30M-2.90M-10.10M-9.00M-10.42M-7.80M-10.60M-9.67M
Operating Margin------------11.38%-233.13%-346.30%-792.20%-4663.65%-82.32%-9675.78%-534.20%-23861.21%-366.01%-----5669.16%-3425.29%-26371.59%-2942.42%-794.73%-3252.00%-2615.93%-1456.99%-583.84%-2237.36%
EBITDA-4.87M-494.00K-428.00K-584.00K25.00K-445.00K169.00K13.61K153.99K-657.00K-1.58M63.74K-1.40M-1.18M-2.28M-3.45M-366.00K3.61M-1.13M-789.00K-1.22M-9.55M-10.96M1.62M-4.50M-2.84M-2.48M-1.86M-2.30M-2.90M-6.05M-19.39M-9.32M-6.34M-6.16M-8.34M
EBITDA Margin-----------5.12%-224.70%-330.02%-766.60%-4442.24%-63.06%-9616.36%-431.41%-23667.38%-3463.46%-----5640.18%-2986.32%-26371.59%-2942.42%-476.00%-7005.50%-2341.08%-1184.04%-339.20%-1929.47%
Net Income-4.90M-527.00K-444.00K-595.00K25.00K-445.00K169.00K13.61K135.76K-660.00K-1.59M-4.97K11.00K-3491.37K-10.22M-11.09M3.16M3.76M-1.61M-1.56M-10.45M-10.52M-759.00K-2.98M-3.27M-2.60M-1.82M-1.72M-3.25M-11.15M-18.20M-8.97M-6.55M-6.93M-7.51M
Net Income Margin------------0.40%1.77%-0.10%0.46%-13150.37%-55.28%31947.04%-878.12%-30219.03%-3789.93%-----5914.81%-2911.02%-19670.94%-3306.79%-877.34%-6575.01%-2252.43%-1224.78%-381.88%-1737.11%
R&D-----------------------70.21K26.17K-1.09M770.84K576.74K515.34K1.59M2.83M3.22M2.70M3.25M4.41M
R&D as % of Total Revenue--------------------------2475.64%1234.97%6606.39%523.77%125.41%1021.88%809.66%504.56%179.28%1020.53%
Interest Expense40.00K33.00K16.00K11.00K----18.23K2.88K6801.91K92---85.72K20.12K---150.00K118.85K119.62K129.27K-000099.20K81.96K59.52K40.77K21.73K20.77K
Interest Expense % of Total Revenue-----------0.15%0.01%----0.35%---54.41%----0.00%0.00%0.00%0.00%7.81%29.62%14.95%7.62%1.20%4.81%

Balance Sheet

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets1.00M622.00K179.00K368.00K2.34M10.50M10.51M11.44M11.33M11.57M9.47M2.87M2.66M3.50M17.44M12.60M2.78M6.13M19.96M19.60M26.85M16.29M4.23M2.82M1.85M3.29M726.90K1.45M7.63M7.37M33.52M30.78M21.51M21.71M18.46M20.45M
Total Liabilities182.00K371.00K202.00K82.00K729.00K776.00K619.00K1.13M882.47K731.34K372.69K544.02K179.85K722.53K556.63K1.55M740.97K466.22K937.46K705.72K246.20K1.19M1.31M1.94M90.42K458.59K468.96K322.65K491.86K899.12K4.46M2.49M1.89M1.72M1.74M1.56M
Total Equity821.00K251.00K-23.00K286.00K1.61M9.72M9.89M10.31M10.44M10.83M9.09M2.31M2.48M2.77M16.87M11.04M2.04M5.67M19.03M18.89M26.60M15.11M2.92M888.13K1.76M2.83M257.94K1.13M7.13M6.48M29.06M28.29M19.62M19.99M16.71M18.89M
Cash37.00K-41.00K3.00K66.00K71.00K6.80M6.02M3.76M2.14M979.11K126.16K668.56K1.04M358.95K2.85M128.39K512.31K1.63M15.28M1.60M961.27K564.57K74.72K29.91K1.73M3.10M650.05K1.45M7.56M7.33M5.00M15.39M7.81M9.23M6.52M9.35M
Total Debt138.00K137.00K161.00K1.00K15.00K9.00K3.00K500.00K--27.35K----706.44K490.10K----1.00M1.16M1.82M-69.39K----1.26M998.69K730.72K776.54K376.19K289.39K
Net Debt101.00K178.00K158.00K-65.00K-56.00K-6.79M-6.02M-3.26M-2.14M-979.11K-98.81K-668.56K-1.04M-358.95K-2.85M578.05K-22.21K-1.63M-15.28M-1.60M-961.27K435.43K1.08M1.79M-1.73M-3.03M-650.05K-1.45M-7.56M-7.33M-3.73M-14.40M-7.08M-8.46M-6.14M-9.06M

Cash Flow

Currency: AUD1991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-198.00K-694.00K-1.45M-1.52M-610.00K-591.98K-943.60K--818.36K-580.86K-1.41M-952.64K-4.68M-5.38M-3.63M-689.60K-807.86K-768.35K-1.54M-703.24K-768.54K99.38K-126.65K-78.12K-2.38M-1.97M-1.57M-2.54M-5.26M-6.06M-7.02M-4.32M-4.66M-6.38M
Investing Cash Flow-88.00K10.00K167.00K-303.00K-260.00K-2.08M-363.41K-3.13M-29.70K-1.03M297.23K-1.08M-5.31M-1.21M2.20M1.81M5.25M-12.92M905.79K-593.46K278.69K-2.74M669.85K0107.98K02.98M2.64M-411.90K-292.27K-174.34K-104.00K-168.33K
Financing Cash Flow289.00K749.00K1.29M8.55M-6.00K896.63K-500.00K1.05M-1.45K2.16M1.51M1.36M12.51M3.86M1.83M-9.21M--900.00K-547.88K-555.66K2.41M-69.39K2.65M7.68M2.31M286.48K16.87M-267.98K5.91M2.05M9.39M
Capital Expenditure0024.00K192.00K181.00K109.44K094.11K064.48K116.78K1.07M432.26K92.90K33.90K11.20K4.57K1746874.56K0000000422.69K785.83K411.90K292.27K174.34K104.00K168.34K
Free Cash Flow-198.00K-694.00K-1.47M-1.72M-791.00K-701.42K-943.60K-94.11K-818.36K-645.34K-1.53M-2.02M-5.12M-5.47M-3.67M-700.80K-812.43K-768.52K-1.54M-707.80K-768.54K99.38K-126.65K-78.12K-2.38M-1.97M-1.57M-2.54M-6.05M-6.47M-7.32M-4.50M-4.77M-6.55M
Dividends Paid--------------1.09M--------618.84K0----265.45K----
FCF to OCF100.00%100.00%101.66%112.59%129.67%118.49%100.00%-100.00%111.10%108.29%212.22%109.23%101.73%100.93%101.62%100.57%100.02%100.04%100.65%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%114.94%106.80%104.16%104.03%102.23%102.64%
Dividend Paid to FCF---------------29.71%---------792.21%0.00%-----4.10%----

Earnings

Report DateJan 29, 2016Oct 19, 2016Feb 28, 2017Sep 29, 2017Feb 28, 2018Aug 31, 2018Feb 28, 2019Aug 18, 2019Feb 25, 2020Aug 24, 2020Feb 26, 2021Aug 31, 2021Feb 25, 2022Aug 30, 2022Feb 24, 2023Feb 20, 2025Aug 25, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00-
EPS Actual0.00-0.010.000.000.000.000.000.000.000.00-0.04-0.12-0.03-0.04-0.06-0.03-0.03
Surprise-----------------
Timing-------------After-hoursPre-market-After-hours

Key Statistics & Ratios

Market Cap23.93M
Enterprise Value16.28M
Trailing P/E0.00
Forward P/E0.00
Price / Sales10.81
Price / Book1.34
EPS-0.06
Book Value0.134
Revenue (TTM)2.21M
Gross Profit (TTM)-2.53M
EBITDA-6.70M
Profit Margin0.00%
Operating Margin-343.78%
Return on Equity-42.16%
Return on Assets-25.40%
Shares Outstanding140.78M
Shares Float115.66M
Beta1.54
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 1, 20201:30
  • Jun 20, 2019121:120
  • Nov 21, 201846:45
  • Sep 11, 20081:10